Skip to main content
OpenTrials
Completed

NCT Number: NCT05915403

Frequency of Sexual Intercourse,Women With Fibromyalgia

Does frequency of sexual intercourse affect symptom severity in female patients with fibromyalgia?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fibromyalgia Behavior Behavioral Symptoms Depression Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neurologic Manifestations Neuromuscular Diseases Pain Pathological Conditions, Signs and Symptoms Rheumatic Diseases Signs and Symptoms

Age range

18 year–55 year

Sex eligibility

Female

Study type

Observational

Primary location

Konya Beyhekim Research and Training Hospital

Konya, Selçuklu, 42060, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female patient with fibromyalgia

Exclusion criteria

  • Uncontrollable systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological),
  • Major psychiatric disease,
  • Endocrine disease,
  • Pregnancy
  • Menopausal status,
  • Antihypertensive, antidepressant, anxiolytic, antiepileptic drugs use

Treatment and study plan

Fibromyalgia Impact Questionnaire

Diagnostic Test

diagnostic tests

Other names: Visual Analog Scale, Beck Depression Inventory, Widespread Pain Index, Symptom Severity Scale, frequency of sexual intercourse

Primary outcomes

  1. Visual Analog Scale

    Time frame: 1 week

    pain level 0-10, higher scores indicate worse outcome

  2. frequency of sexual intercourse

    Time frame: 3 mounths

    mean monthly frequency of sexual intercourse in the last 3 months

  3. Fibromyalgia Impact Questionnaire

    Time frame: 1 week

    0-80, higher scores indicate worse outcome

Secondary outcomes

  1. Beck Depression Inventory

    Time frame: 1 week

    0-63, higher scores indicate worse outcome

  2. Widespread Pain Index

    Time frame: 1 week

    0-19, higher scores indicate worse outcome

  3. Symptom Severity Scale

    Time frame: 1 week

    0-12, higher scores indicate worse outcome

Sponsors and collaborators

Lead sponsor

Konya Beyhekim Training and Research Hospital

Other Gov

Registry information

Official study title

The Effect of Frequency of Sexual Intercourse on Symptoms in Women With Fibromyalgia

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Jun 23, 2023
Registry last updated
Jun 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.